Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 21, 2020 | Post-IPO Secondary | $220M | — | — | — | Detail |
Sep 11, 2019 | Post-IPO Equity | $115M | — | — | — | Detail |
Oct 20, 2016 | IPO | $107M | — | — | — | Detail |
May 22, 2014 | Series E | $27.34M | 2 | Novo Holdings | — | Detail |
Apr 10, 2013 | Series D | $16M | 5 | Norwest Venture Partners | — | Detail |
Nov 19, 2012 | Series Unknown | $1.50M | 1 | California HealthCare Foundation | — | Detail |
Nov 13, 2012 | Debt Financing | $3.49M | — | — | — | Detail |
Jan 26, 2012 | Series Unknown | $22.14M | — | — | — | Detail |
Jan 1, 2012 | Private Equity(PE) | $12.18M | 4 | — | — | Detail |
Oct 26, 2011 | Series C | $7M | — | — | — | Detail |
May 4, 2011 | Series C | $15M | 3 | New Leaf Venture Partners | — | Detail |
May 20, 2010 | Series Unknown | $10M | 3 | — | — | Detail |
May 18, 2009 | Series B | $6.50M | 3 | — | — | Detail |
Feb 8, 2007 | Series A | $12M | 3 | Mohr Davidow Ventures , Synergy Life Science Partner | — | Detail |